TNXP Research and Charts

TNXP - Tonix Pharmaceuticals Holding Corp (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-09 (Delayed quote data 2025-01-06)

Last 0.31	Change ⇓ 0.00 (0.00%)	Volume 82,347,753
	Open 0.33	High 0.34	Low 0.31

8EMA (Daily) 0.34	40EMA (Daily) 0.29	50EMA (Daily) 0.29	STO (Daily) 9.827	MACD Hist (Daily) -0.030
8EMA (Weekly) 0.304	40EMA (Weekly) 7.00	50EMA (Weekly) 24.51	STO (Weekly) 33.331	MACD Hist (Weekly) 1.749


Company Profile
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is engaged in discovering, licensing, acquiring and developing drugs and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes biologics to prevent infectious diseases and small molecules and biologics to treat pain, psychiatric and addiction conditions. While the company is also developing a potential vaccine to protect against the novel coronavirus disease. Its main products are used for treating fibromyalgia, or FM, and posttraumatic stress disorder, or PTSD.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.